Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Chemical & Pharmaceutical Bulletin|October 2, 2008
Design and synthesis of cinanserin analogs as severe acute respiratory syndrome coronavirus 3CL protease inhibitorsQingang Yang, Lili Chen, Xuchang He, et al.BMC Pharmacology|August 26, 2010
Salvianolic acid B functioned as a competitive inhibitor of matrix metalloproteinase-9 and efficiently prevented cardiac remodelingBaohong Jiang, Jing Chen, Lingling Xu, et al.Biochemical Pharmacology|January 1, 2008
Deoxyelephantopin inhibits cancer cell proliferation and functions as a selective partial agonist against PPARgammaGang Zou, Zhenting Gao, Jidong Wang, et al.BMC Bioinformatics|February 20, 2008
PDTD: a web-accessible protein database for drug target identificationZhenting Gao, Honglin Li, Hailei Zhang, et al.Journal of Virology|April 26, 2013
Conformational plasticity of the 2A proteinase from enterovirus 71Qixu Cai, Muhammad Yameen, Weihua Liu, et al.Nucleic Acids Research|July 18, 2006
TarFisDock: a web server for identifying drug targets with docking approachHonglin Li, Zhenting Gao, Ling Kang, et al.Nature Chemical Biology|October 13, 2022
Targeting androgen receptor phase separation to overcome antiandrogen resistanceJingjing Xie, Hao He, Wenna Kong, et al.Journal of Medicinal Chemistry|August 7, 2012
Discovery and optimization of 1,3,4-trisubstituted-pyrazolone derivatives as novel, potent, and nonsteroidal farnesoid X receptor (FXR) selective antagonistsHuang Huang, Ying Yu, Zhenting Gao, et al.Plos One|January 11, 2017
Discovery and Molecular Basis of a Diverse Set of Polycomb Repressive Complex 2 Inhibitors Recognition by EEDLing Li, Hailong Zhang, Man Zhang, et al.Journal of Medicinal Chemistry|January 17, 2017
Discovery of First-in-Class, Potent, and Orally Bioavailable Embryonic Ectoderm Development (EED) Inhibitor with Robust Anticancer EfficacyYing Huang, Jeff Zhang, Zhengtian Yu, et al.Pageof 2